Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The future of gene therapy

Nature volume 427, pages 779–781 (2004)Cite this article

Balancing the risks and benefits of clinical trial.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cavazzana-Calvo, M. et al. Science 288, 669–672 (2000).

    Article  ADS  CAS  Google Scholar 

  2. Aiuti, A. et al. Science 296, 2410–2413 (2002).

    Article  ADS  CAS  Google Scholar 

  3. Hacein-Bey-Abina, S. et al. Science 302, 415–419 (2003).

    Article  ADS  CAS  Google Scholar 

  4. Fischer, A. Lancet 357, 1863–1869 (2001).

    Article  CAS  Google Scholar 

  5. Antoine, C. et al. Lancet 361, 553–560 (2003).

    Article  Google Scholar 

  6. Bonini, C. et al. Nature Med. 9, 367–369 (2003).

    Article  CAS  Google Scholar 

  7. Dave, U. P., Jenkins, N. A. & Copeland, N. G., Science 303, 333 (2004).

    Article  Google Scholar 

  8. Baum, C. et al. Blood 101, 2099–2114 (2003).

    Article  CAS  Google Scholar 

  9. Williams, D. A. & Baum, C. Science 302, 400–401 (2003).

    Article  CAS  Google Scholar 

  10. http://www.emea.eu.int/index/indexh1.htm

Download references

Acknowledgements

The authors report the shared opinion of the scientists and clinicians who developed and performed gene therapy of SCIDs in France, Italy and the United Kingdom, and in particular of Alessandro Aiuti, Claudio Bordignon, Alain Fischer, Salima Hacein-Bey-Abina and Maria Grazia Roncarolo.

Author information

Authors and Affiliations

  1. the Immunology and Pediatric Haematology Unit, Hospital Necker, Paris, 75743 Cedex 15, France

    Marina Cavazzana-Calvo

  2. the Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK

    Adrian Thrasher

  3. Department of Biomedical Sciences, University of Modena, Via Campi 287, Modena, 41100, Italy

    Fulvio Mavilio

  4. the Istituto Scientifico H. San Raffaele, Via Olgettina 58, Milano, 20132

    Fulvio Mavilio

Authors
  1. Marina Cavazzana-Calvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrian Thrasher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fulvio Mavilio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cavazzana-Calvo, M., Thrasher, A. & Mavilio, F. The future of gene therapy. Nature 427, 779–781 (2004). https://doi.org/10.1038/427779a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/427779a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing